SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-17-205389
Filing Date
2017-06-16
Accepted
2017-06-16 10:15:36
Documents
2
Group Members
PROSIGHT FUND, LPPROSIGHT PARTNERS, LLCPROSIGHT PLUS FUND, LPW. LAWRENCE HAWKINS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d496710dsc13g.htm SC 13G 100311
2 EX-99.1 d496710dex991.htm EX-99.1 13009
  Complete submission text file 0001193125-17-205389.txt   115087
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Subject) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88806 | Film No.: 17915000
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2301 CEDAR SPRINGS ROAD, SUITE 355 DALLAS TX 75201
Business Address 2301 CEDAR SPRINGS ROAD, SUITE 355 DALLAS TX 75201 214-468-0008
Prosight Management, LP (Filed by) CIK: 0001617201 (see all company filings)

IRS No.: 263706721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G